주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Saturday, Aprill 27, 2024, 14:40
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Celltrion Completes US Patent Registration for Zymfentra
Jasmine Choi
2024.04.12 10:16
Celltrion Confirms Safety in Phase 1 Trial of Oral Treatment for Autoimmune Diseases
Choi Mun-hee
2024.02.07 11:17
Integrated Celltrion to Launch: Global Big Pharma Firm with 12 Trillion Won Revenue
Choi Mun-hee
2023.12.28 09:09
Samsung Bioepis, Celltrion Both Confirm Efficacy of Stelara Biosimilars
Jung Min-hee
2023.10.13 11:26
Celltrion Obtains Sales Approval in Australia for Avastin Biosimilar 'Vegzelma'
Jasmine Choi
2023.09.04 22:15
Celltrion Group Begins Merger Procedure with Celltrion Healthcare
Jasmine Choi
2023.08.18 08:03
Samsung Bioepis Considering Acquisition of Biogen’s Biosimilars Business in US
Jasmine Choi
2023.08.02 18:18
Biopharmaceuticals Added to National Strategic Technology List, Eligible for Up to 35% Tax Deduction
Kim Eun-jin
2023.07.28 11:08
Samsung Bioepis, Humira Biosimilar Listed by US PBM Prime
Jasmine Choi
2023.07.14 10:42
June data confirms favorable XCopri prescription growth
Pyeongkuk Park
2023.07.10 17:40
Samsung Bioepis, Celltrion to Target US$20 Billion US Humira Similar Market
Jung Suk-yee
2023.07.03 09:38
South Korean New Drugs Enjoying Sales Growth in the U.S.
Choi Moon-hee
2023.02.27 11:50
처음
1
2
3
4
5
6
7
8
9
10
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기